Pharmacopeia Books

Product Details:

Printed Book Format 
365 Pages

2020 , 1st Ed.
Published by FAFAI, India

 

The Fragrances and Flavours Association of India (Fafai) has come up with a reference Book which list more than 9,000 ingredients used and generally considered safe that are used in making a wide range of fragrance and flavour based products in the country.

This is the first edition of Indian Fragrances and Flavours Reference List of Ingredients which will become a standard document and reference book for the industry to follow and use.

This Comprehensive Book Contains :

• List of Ingredients for Fragrances - 6200 ingredients Contains information on Common Name , FEMA No. CAS No. & Synonyms
• List of Ingredients For Flavours - 3000 Ingredients Contains information on Common Names, CAS No. , JECFA No., FEMA GRAS NO.  EU FL. No.

 

A Handy Ready Reckoner ! One Source information on over 9000 Materials Natural as well as Synthetic

Additional Information:

• Production Capacity: 250
• Delivery Time: Immediate

Product Details:

Includes USP 42 and NF 37. Published in November 2018.

United States Pharmacopoeia 2019 USP 42–NF 37 – the new edition for 2019 – publishes in English in November 2018. Ensure that you have time to prepare for important standards changes that become official and FDA – enforceable beginning May 1, 2019.

The United States Pharmacopeia–National Formulary (USP–NF) is a book of public pharmacopeial standards. It contains standards for medicines, dosage forms, drug
substances, excipients, medical devices, and dietary supplements.

The USP–NF is a combination of two official compendia, the United States Pharmacopeia (USP) and the National Formulary (NF). Monographs for drug substances and preparations are featured in the USP. Monographs for dietary supplements and ingredients appear in a separate section of the USP. Excipient monographs are in the NF.

Additional Information:

• Delivery Time: 2 days

Product Details:

The BP 2019 supersedes the BP 2018 and becomes legally effective on 1 January 2019. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.

Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.

It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.

All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.

The standard package includes a printed edition, an online licence and a download for offline use; but other formats and bundles are available.

Add the BP Archive option to your standard package and receive online access to all the BP editions from 2014 to date. The Archive is a useful tool that enables you to switch between different versions of a monograph by publication to help users track what's changed.

New for 2019

• 27 new BP monographs, 39 new Ph. Eur. monographs

• 117 amended BP monographs

• Four new monographs for unlicensed formulations and two new monographs for herbal preparations

• Two new monographs for biological medicines

• One new and six amended BP Veterinary monographs

• All monographs from the Ph. Eur. 9th Edition and Supplements 9.1 to 9.5 included

• Three in-year online and offline download product updates to integrate the Ph. Eur. Supplements 9.6, 9.7 and 9.8

The British Pharmacopoeia 2019 package consists of

• A six-volume printed edition, including the BP (Veterinary) 2019

• A single-user online licence*

• A single-user download for offline use*

*These single-user licences are granted solely to the designated holder of the product within an organisation. Multi-user licences are available.

Additional Information:

• Delivery Time: Immediate
• Packaging Details: 6 x Volumes in slipcase 248 x 368 x 239mm

Product Details:

‘Get access to harmonised quality standards applicable in Europe from 1 January 2020’ The 10th Edition at a glance

The Pharmacopoeia you need to comply with in order to market your products in 38 European countriesand beyond.

It delivers crucial information earlier than any other pharmacopoeia.

With 114 newand 683 revised texts, approximately 30% of the content is new or revised compared to Edition 9.0.

It contains 2420 monographs, 374 general texts (including general monographs and methods of analysis) and around 2 780 descriptions of reagents.

 10thEdition print version: the 2020 subscription will consist of the first 3 volumes (10.0) and the first 2 non-cumulative updates, 10.1 and 10.2, and will provide access to the Ph. Eur. online archives until 31 December 2020
Initial release and updates
The 10th edition of the Ph. Eur. will be released in July 2019 and will be updated with 8 supplements over the next 3 years (10.1 to 10.8). 
 

Print version:the 10th Edition consists of 3 initial volumes (10.0) complemented by 8 non-cumulative supplements (10.1 to 10.8). For the convenience of users, direct access to complementary information (Knowledge Database) is included for each monograph and general chapters through a data matrix code. Available in either English or French, the print version contains a subscription key (EPID code) that allows access to online archives.

Additional Information:

• Delivery Time: Immediate

Product Details:

The British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare products Regulatory Agency (MHRA) 
Publisher: TSO (The Stationery Office)

New, legally enforced standards, available from 1 August 2019. All European Pharmacopoeia texts included.

Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.

It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.

All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.

New for the BP 2020

The BP 2020 supersedes the BP 2019 and becomes legally effective on 1 January 2020. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.

• 35 new BP monographs, 40 new Ph. Eur. monographs
• 331 amended BP monographs
• All monographs from the Ph. Eur. 9th Edition and Supplements 9.1 to 9.8 included
• Ph. Eur. 10th edition, plus supplements 10.1 and 10.2 included as in-year online and download product updates
• New Timeline Functionality (opens in new window) and cleaner design helps you find the information you need more effectively. Easily see updates, withdrawals and omissions of monographs. Archive subscribers can now identify all previous editions of BP and Ph. Eur., through the improved navigation.
• We're releasing 16 new BPCRS to coincide with the new and revised monographs in the BP 2020. This means that you can order the new chemical reference standards alongside the BP 2020 - helping you comply with the new standards by January 2020.

Product Details:

Available from 1 August 2021 | Effective from 1 January 2022 | Superseding the BP 2021


he BP 2022 complete package

 

The British Pharmacopoeia (BP) 2022 is the most comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products. It includes around 4,000 monographs including the BP (Veterinary) and all European Pharmacopoeia (Ph. Eur.) monographs, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.

Why use the BP?

If a pharmaceutical substance or finished product is marketed in a country where the BP is a legal standard, it must comply with the requirements of the BP throughout its shelf life.

 

What's included?

In addition to all European Pharmacopoeia texts being included, the new edition also features:

Monographs and content updates:

• 25 new BP monographs, 38 new Ph. Eur. monographs.
• 133 amended BP monographs.
• All monographs from the Ph. Eur. 10th edition as amended by Supplements 10.1 to 10.5 are included. 
• Ph. Eur. supplements 10.6, 10.7, and 10.8 included as in-year online and download product updates. 
• We're releasing new BPCRS to coincide with the new and revised monographs in the BP 2022. This means you can order the new chemical reference standards alongside the BP 2022 - helping you comply with the new standards from January 2022.

Additional Information:

• Delivery Time: Immediate
• Packaging Details: Box contains 6 Volumes Set + Online access

New, legally enforced standards, effective from 1 January 2018. All European Pharmacopoeial texts included.

The British Pharmacopoeia (BP) 2018 supersedes the BP 2017 and becomes legally effective on 1 January 2018. This edition incorporates new BP and European Pharmacopoeia monographs and a significant number of revised monographs.

To ensure you get the best value access to the information you need, there are a range of flexible licences, formats and package options available to choose from.

The BP 2018 packageNew for the 2018 BP:

• 35 new BP monographs, 39 new Ph. Eur. monographs

• 185 amended BP monographs

• Four new monographs for unlicensed formulations

• Four new monographs for herbal medicines

• A new Supplementary Chapter on Raw materials of Biological Origin for the Production of Cell-based and Gene Therapy Medicinal Products

• All European Pharmacopoeia monographs integrated (9th Edition as amended by Supplements 9.1 to 9.2)

• Three in-year website and offline download updates to harmonise with the European Pharmacopoeia Supplements 9.3, 9.4 and 9.5

This edition of the Pharmacopoeia of the People’s Republic of China ( known as Chinese Pharmacopoeia 2010 or in abbreviation as ChP 2010 ) has been prepared in accordance with the principles and requirements recommended by the Ninth Pharmacopoeia Commission and accomplished with the effort made by Commission members and its Secretariat and with collaborated support of relevant institutions and organizations. The draft text has been reviewed and approved by the Executive Committee of the Pharmacopoeia Commission. This is the ninth edition of Chinese Pharmacopoeia since the founding of the People’s Republic of China.

Chinese Pharmacopoeia 2010 is published in three volumes, and contains up to 4567 monographs with 1386 new admissions. In Volume I, it contains monographs of Chinese crude drugs and the prepared slices. Vegetable oil/fat and its extract, the patented Chinese traditional medicines, single ingredient of Chinese crude drug preparations etc. it has 2165 monographs with 1019 new admissions (439 articles of the prepared slice) and 634 revised; Volume II deals with monographs of chemical drugs, , biochemical preparations, radiopharmaceuticals and excipients for pharmaceutical use, contains 2271 monographs with 330 new admissions and 1500 revised; Volume III contains biological products, has 131 monographs with 37 new admissions and 94 revised.

The number of articles in Appendices of this edition is much varied. There are 14 new admissions and 47 revised, in Volume I. There are 15 new admissions and 69 revised in Appendices of Volume II. There are 18 new admissions and 39 revised in Appendices of Volume III. Appropriate monographs common to all three volumes are presented in each volume respectively in a harmonized and unified form.

The main changes in the revision of this edition of Chinese Pharmacopoeia are as follows:

• Monographs adopted in this edition of Chinese Pharmacopoeia are significantly increased comparing with previous editions
• Applications of contemporary techniques of analysis is further enhanced and stressed in this edition
• The guarantee of pharmaceutical safety is further strengthened
• The controllability and effectiveness of drug quality are further improved
• The contents of drug standards are scientific and normative
• Encouraging technical innovation, actively participating in international coordinatioin